Medical Articles 2/25

Posted by rob on February 25, 2007 under Uncategorized | Be the First to Comment

Dasatinib
or high-dose imatinib for chronic-phase chronic myeloid leukemia after
failure of first-line imatinib: a randomized phase-II trial.
Important therapeutic targets in chronic myelogenous leukemia.
Synthesis and inhibition of cancer cell proliferation of (1,3′)-bis-tetrahydroisoquinolines and piperazine systems.
Massive
pulmonary embolism after treatment with rFVIIa in a thrombocytopenic
patient with acute myelogenous leukemia and intractable bleeding.
Torsades de pointes associated with voriconazole use.
Adenoviral
E1B55K oncoprotein sequesters candidate leukemia suppressor
sequence-specific single-stranded DNA-binding protein 2 into aggresomes.
Monoclonal antibody-based therapeutics for leukemia.

Add A Comment

You must be logged in to post a comment.

home top